Clinical Trial Update: Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of Guanabenz for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Guanabenz (guanabenz)

Snippet

Sponsor: Yokohama City University | Conditions: Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis | Phase 2 | Status: UNKNOWN